For example, the TMPRSS2 inhibitors camostat and nafamstat are protease inhibitors approved in Japan for treating pancreatitis, and known to inhibit TMPRSS2 (Shrimp et al., 2020). Here, TMPRSS2 is linked to pancreatitis.